Gladstone Institutes

gladstoneinst.bsky.social

31 March 2026 19:00

A new study—led by Justin Eyquem from The Gladstone-UCSF Institute of Genomic Immunology —uses a dual-vector system to engineer cancer-fighting T cells in vivo, potentially simplifying and expanding access to these life-saving therapies. @j-eyquem.bsky.social

UCSF Helen Diller Family Comprehensive Cancer Center

ucsfcancer.bsky.social

24 March 2026 20:44

“I think this is just the beginning of a big wave of new therapies that will be truly transformational and save a lot of lives” Justin Eyquem, PhD @j-eyquem.bsky.social @ucsanfrancisco.bsky.social on recent @nature.com pub with breakthrough research on CAR T therapy www.ucsf.edu/news/2026/03...

Waggoner Lab

labwaggoner.bsky.social

18 March 2026 17:54

A gene-editing method generates immunotherapeutic CAR T cells in the body @nature.com @j-eyquem.bsky.social @ucsfhealth.bsky.social @ki.se www.nature.com/articles/d41... @heidiledford.bsky.social www.nature.com/articles/d41... www.nature.com/articles/s41...

Innovative Genomics Institute

innovativegenomics.bsky.social

18 March 2026 17:15

Out today in @nature.com a team of researchers across @ucsanfrancisco.bsky.social, @ucberkeleyofficial.bsky.social, and Duke University led by IGI Investigator @j-eyquem.bsky.social use #CRISPR — in vivo — to create cancer-fighting immune cells. Learn more: innovativegenomics.org/news/in-vivo...

Kapalı içerik